obesity drug news today glp-1 october 27 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 therapies are changing obesity

population has a 34% prevalence of obesity and 11% for diabetes (overwhelmingly Type 2)

IV Glutathione is a great choice if you want to detoxify your body and improve your skin

RNA sequencing In vitro OA-like chondrocyte model was first established by stimulating primary chondrocytes with t-BHP for 24 h

Proton nuclear magnetic resonance (NMR) facilitates quantitative and qualitative pyruvate analysis

More new compounds have been added as possible tools for anti-cancer therapies, being characterized by a more selective mechanism and fewer side effects, resulting in better anti-cancer responses and/or fewer side effects